Purchase Order 75N91023P00841
Award Date 9/1/23
Potential Completion Date 10/31/23
Potential Value $25K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98109, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,741 purchase order to Nanostring Technologies, Inc. of Seattle, Washington for reagents. The firm fixed price contract runs from August 25, 2023 through September 25, 2023 and supports the NIH NCI's research efforts. As a leading provider of life science tools for translational research and molecular diagnostic products, Nanostring will deliver the requested reagents to aid in the...
- Nanostring Technologies, Inc. received a $20,442.50 firm fixed-price blanket purchase agreement (BPA) call from the National Cancer Institute on April 12, 2024, with completion scheduled for July 12, 2024. This supplies contract, which carries no set-aside designation, represents a task order under an existing BPA vehicle and will be performed in Seattle, Washington. The award supports the National Cancer Institute's research mission by providing specialized genomic analysis products or services...
- The National Cancer Institute awarded Nanostring Technologies, Inc. a $5,974.50 firm fixed price call against a blanket purchase agreement for biological materials, chemicals, and laboratory supplies on April 17, 2018. The contract, which was not set aside for small businesses, represents a delivery order for specialized genomic analysis consumables and reagents to support the National Cancer Institute's research initiatives. The work was completed by May 17, 2018, with performance taking...
- Nanostring Technologies, Inc. was awarded a $25K firm fixed price blanket purchase agreement (BPA) call from the National Cancer Institute (NCI), a component of the National Institutes of Health, with a completion date of October 6, 2017. The award was issued without a set-aside designation and utilized existing BPA terms to procure specialized genomic analysis products or services from the Seattle, Washington-based vendor. This procurement aligns with NCI's mission to support cancer research...
- The National Cancer Institute awarded a $10,892 firm fixed-price BPA (Blanket Purchase Agreement) call to Nanostring Technologies, Inc. on June 27, 2017, with a completion date of July 27, 2017. This contract represents a delivery order against an existing blanket purchase agreement and was performed at Nanostring's Seattle, Washington facility. No set-aside designation was applied to this award. Nanostring Technologies is a publicly traded provider of advanced genomic analysis platforms and...
- The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded a $41,280.50 firm fixed-price purchase order to Nanostring Technologies, Inc., a small business manufacturer, for NanoString CosMx Spatial Gene Expression Library Preparation Kits. This purchase order is likely related to a larger federal contract vehicle utilized by the NCI and other agencies to procure Nanostring's specialized genomic analysis platforms, assays, and related services to support...
- Nanostring Technologies, Inc. has been awarded a $49,500 purchase order by the National Cancer Institute (NCI), a component of the Department of Health and Human Services' National Institutes of Health (HHS-NIH), to provide an upgrade to geomagnetic data signal processing (GEOMX DSP) software. The firm fixed price contract runs from September 2022 through March 2024 and will be performed in Potomac, Maryland. As the prime contractor, Nanostring will deliver upgraded software to support NCI's...
- The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a firm-fixed-price purchase order to Nanostring Technologies, Inc., a for-profit manufacturer of life science tools, for the provision of NanoString GeoMX Digital Spatial Profiling and nCounter MAX System equipment and services to support the Laboratory of Pathology's Single-Cell RNA Facility. The $496,250 contract has a completion date of September 3, 2020 and does not utilize a...
- The National Cancer Institute awarded a $24,743 firm fixed price Blanket Purchase Agreement (BPA) call to NanoString Technologies, Inc. for biological kits on April 30, 2024, with an ultimate completion date of May 29, 2024. The contract, which carries no set-aside designation, will be performed in Seattle, Washington. NanoString Technologies is a publicly traded provider of advanced genomic analysis platforms and life science tools, specializing in multiplexed digital detection technologies...
- Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools, was awarded a $22.3K blanket purchase agreement (BPA) call by the National Cancer Institute on June 5, 2024, for laboratory supplies. The contract is firm fixed-price with no set-aside designation and is scheduled for completion by September 30, 2024. The work will be performed at the contractor's Seattle, Washington facility. This award represents a continuation of...